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In Brief
In immature pancreatic beta cells, high
glucose does not prompt an increase in
insulin secretion. Huang et al. show that
this poor response is due to greater Ca2+
sensitivity in immature cells, producing a
higher basal secretion rate. Furthermore,
Ca2+ sensitivity is regulated by
synaptotagmin 4, whose levels increase
during maturation.
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Islet b cells from newborn mammals exhibit high
basal insulin secretion and poor glucose-stimulated
insulin secretion (GSIS). Here we show that b cells
of newborns secrete more insulin than adults in
response to similar intracellular Ca2+ concentrations,
suggesting differences in the Ca2+ sensitivity of insu-
lin secretion. Synaptotagmin 4 (Syt4), a non-Ca2+
binding paralog of the b cell Ca2+ sensor Syt7,
increased by 8-fold during b cell maturation. Syt4
ablation increased basal insulin secretion and
compromised GSIS. Precocious Syt4 expression
repressed basal insulin secretion but also impaired
islet morphogenesis and GSIS. Syt4 was localized
on insulin granules and Syt4 levels inversely related
to the number of readily releasable vesicles. Thus,
transcriptional regulation of Syt4 affects insulin
secretion; Syt4 expression is regulated in part
by Myt transcription factors, which repress Syt4
transcription. Finally, human SYT4 regulated GSIS
in EndoC-bH1 cells, a human b cell line. These find-
ings reveal the role that altered Ca2+ sensing plays
in regulating b cell maturation.DeveINTRODUCTION
Whole-body euglycemia is mediated in large part by insulin
secreted from islet b cells. However, the precise mechanisms
that govern insulin secretion, particularly in neonates, have not
been completely characterized. In contrast to adult islet b cells,
fetal and neonatal cells secrete more insulin in response to low
basal glucose levels and have only modest glucose-stimulated
insulin secretion (GSIS) (Grasso et al., 1968; Pildes et al.,
1969). There are many potential stages at which GSIS can be
regulated in b cells, including gap junctional or paracrine
communication among islet cells, intracellular glucose meta-
bolism, glucose-stimulated Ca2+ entry, as well as insulin vesicle
formation, fusion, and release (Liu and Hebrok, 2017 and refer-
ences therein). Understanding the post-natal maturation of the
b cell secretory response will provide important insight for
producing functional and therapeutically relevant b cells from
human embryonic stem cells (ESCs)/induced pluripotent stem
cells in vitro, as this process represents a major limiting step in
their generation (Kieffer, 2016). Such knowledge will presumably
also provide an understanding of islet b cell dysfunction in
diabetes.
Several pathways and transcription factors (TFs) have been
suggested to direct post-natal b cell development. For example,
Ca2+/calcineurin signaling facilitates b cell maturation by pro-
moting insulin vesicle biogenesis (Goodyer et al., 2012); thyroidlopmental Cell 45, 347–361, May 7, 2018 ª 2018 Elsevier Inc. 347
hormones activate expression of the MafA TF (Aguayo-Mazzu-
cato et al., 2013), which enhances the transcription of insulin
and GSIS-related genes (Hang and Stein, 2011); secretory
molecules, includingUcn3 from b cells (via somatostatin in d cells
[Blum et al., 2012; van der Meulen et al., 2015]) and neurotrans-
mitters/hormones, can modulate b cell secretion by regulating b
cell signal transduction or vesicular properties (Scarlett and
Schwartz, 2015). Inactivation of several other TFs, including
NeuroD (Gu et al., 2010) and Myt1 (Wang et al., 2007) reduce
GSIS, suggesting that their roles in post-natal b cell maturation.
In part, NeuroD1 functions through repression of glycolytic
enzyme expression (Gu et al., 2010), although how Myt1 regu-
lates b cell function remains unclear, largely due to the redun-
dancy with two paralogs, Myt1L (Nzf1) and St18 (Nzf3) (Wang
et al., 2007). How these pathways and signals integrate to
control the changes in b cell GSIS that occur during maturation
remains unknown.
Changes in glucose metabolism and ATP-regulated channel
activity play an important part in improving GSIS during b cell
maturation (Rorsman et al., 1989). This entails reduced ex-
pression of various enzymes favoring glycolysis (e.g., hexoki-
nases and lactate dehydrogenase, or disallowed factors) and
increasing transcript abundance of those facilitating mitochon-
drial oxidative phosphorylation (Lemaire et al., 2016). Themolec-
ular mechanisms regulating the expression of these metabolic
enzymes involve epigenetic modifications (Dhawan et al.,
2015), microRNAs (Jacovetti et al., 2015), and nuclear receptors
(Yoshihara et al., 2016).
Although changes in metabolism lead to changes in ion chan-
nel activity, these pathways are not sufficient to induce the alter-
ations in GSIS that occur during b cell maturation. Notably, influx
of Ca2+, a key mediator of insulin secretion, is similar in P2
(2 days after birth) and adult b cells (Rozzo et al., 2009) even
though physiological GSIS is not observed until post-natal day
9 (P9) or later (Blum et al., 2012; Nishimura et al., 2006). The num-
ber of releasable insulin vesicles does not limit the P2 GSIS
response, since these b cells possess high basal and KCl-stim-
ulated insulin secretion properties (Blum et al., 2012). These
observations suggest that under-developed Ca2+-secretion
coupling of immature b cells could contribute to their impaired
glucose responses. To this end, the availability of vesicles for
release and/or Ca2+ sensitivity of vesicle fusion with the plasma
membrane could contribute to this immaturity (Kalwat and
Cobb, 2017). Indeed, many components of the SNARE (soluble
N-ethylmaleimide-sensitive factor attachment protein receptor)
vesicle fusion complex are Ca2+ sensitive, including syntaxin
1A, synaptosomal-associated protein 25, and synaptotagmins
(Syts). The Syts are particularly interesting because they are
known to regulate Ca2+-secretion coupling in nerve cells
(Craxton, 2004; S€udhof, 2012). Although Syt7 is reported to pro-
mote insulin secretion (Dolai et al., 2016; Gustavsson et al., 2008;
Wu et al., 2015), the broader influence of the Syt family of pro-
teins in b cell maturation and GSIS is unknown.
There are 17 distinct Syt-encoding genes in mammals. Their
ability to stimulate secretion depends on Ca2+ binding (Berton
et al., 2000; Dean et al., 2009; Fukuda et al., 2003). Those that
have a high affinity for Ca2+ (Syt1, 2, 3, 5, 6, 7, 9, and 10) can
potentiate microsome fusion (Bhalla et al., 2008), while those
which lack significant Ca2+ affinity repress SNARE-mediated348 Developmental Cell 45, 347–361, May 7, 2018membrane fusion (Bhalla et al., 2008; Littleton et al., 1999;
Thomas et al., 1999). For example, Syt4 can inhibit vesicle secre-
tion in cochlear inner ear hair cell synapses or PC12 cells (John-
son et al., 2010; Machado et al., 2004; Moore-Dotson et al.,
2010), which involves direct binding of Syt4 to Ca2+-sensitive
Syt1 (Littleton et al., 1999).
Here we demonstrate that insulin vesicles in immature b cells
have higher sensitivity to cytoplasmic Ca2+ levels, which is regu-
lated by Syt4. Moreover, we provide evidence that elevated Syt4
expression, partially regulated by Myt TFs, during b cell matura-
tion plays a key role in regulating the GSIS response.
RESULTS
The Improvement in GSIS Is Not Regulated by Ca2+ Entry
into Maturing Islet b Cells
Depolarization-induced Ca2+ entry is the trigger for insulin
secretion in b cells (Rorsman and Renstro¨m, 2003). To
examine if there was a difference in depolarization-stimulated
insulin secretion (DSIS) between immature (P1 or P4) and
mature islet b cells (P12 or adults), extracellular potassium
was elevated to depolarize the cell membrane potential and
activate voltage-gated Ca2+ channels (VGCCs). Glucose-inde-
pendent DSIS occurred in each of these b cell populations
(Figure 1A, left columns). Immature b cells actually showed
greater (4-fold) DSIS following a 10- or 45-min KCl stimula-
tion (Figure 1A), a temporal response similar to the first and
second phase of GSIS (Rorsman and Renstro¨m, 2003). Addi-
tion of 2.8 mM glucose during DSIS produced findings compa-
rable with KCl alone, with immature b cells secreting 4-fold
more insulin than mature b cells (Figure 1A, right columns).
The higher levels of insulin secretion in immature b cells could
not be explained by the amount of insulin within each b cell,
because mature cells contain 1.6-fold more insulin than imma-
ture b cells (Figure 1B). Nor is it a result of differing quantities
of insulin in each vesicle, as the diameter of the dense insulin
protein core was similar between immature and mature b cells
(Figures S1A–S1E).
These findings suggest that immature b cells undergo a
greater number of secretion events following a depolarizing stim-
ulus than mature cells, which might be explained by differences
in cytoplasmic Ca2+ handling. Although KCl treatment induced b
cell cytoplasmic Ca2+ influx in islets of all stages (Figure 1C), the
total amount of KCl-induced Ca2+ entry was significantly higher
in mature b cells compared with immature b cells (Figures 1D
and 1E). However, immature b cells (P1, P4) had a higher con-
centration of basal cytoplasmic Ca2+ compared with mature b
cells (P12, adult [Blum et al., 2012]) (Figure 1C, 120%), consis-
tent with their higher glycolysis rate (Jermendy et al., 2011).
These data suggest that the greater DSIS in immature b cells is
not a result of elevated Ca2+ influx.
It is also possible that changes in VGCC isoforms or sub-
cellular localization influence Ca2+ entry and insulin secretion
during maturation. To test this, we monitored insulin secretion
from islets treated with a K+ channel activator (i.e., diazoxide)
and an ionophore (ionomycin) to induce equivalent Ca2+ entry
across the entire b cell membrane without VGCC activation
(Do et al., 2014). Under these conditions, the immature islets
again showed 3-fold higher insulin secretion compared with
Figure 1. Equivalent Ca2+ Influx Results in
More Insulin Secretion in Immature b Cells
Handpicked islets were used for secretion and
Ca2+ assays.
(A) The percentage of insulin secretion induced by
25 mM KCl in islets at 0 (left columns) or 2.8 mM
(right columns) glucose. Data from three time
points, before KCl stimulation (‘‘0’’), 10 or 45 min
(m) with KCl stimulation (‘‘10’’ or ‘‘45’’) were pre-
sented. The data at 0 min represent insulin secre-
tion within a 45-min time window without KCl
stimulation. The indicated statistical analysis (top
brackets) was calculated between P1 and P12
islets.
(B) Insulin content per b cell, assayedwith purified b
cells of RipmCherry mice.
(C) Average islet cytoplasmic Ca2+ responses to
25mMKCl-induced depolarization in 2.8 mMbasal
glucose; these responses were assayed with
Fura2AM.
(D) Quantification of the KCl-induced islet Ca2+
response defined with area-under-curve after KCl
addition (from 2 to 8 min).
(E) The greatest total Ca2+ levels reached in islets of
different ages stimulated by 25 mM KCl.
(F) Insulin secretion induced by ionomycin (Iono) in
P1 and adult islets. Diazoxide (Dia) was included in
these assays.
(G) Islet DSIS with or without glucose-induced
degranulation, achieved by incubating islets in
5.6 mM glucose for 1 hr prior to DSIS.
Error bars represent the SEM. *p < 0.05, t test.mature islets (Figure 1F), suggesting that the hyper insulin secre-
tion in immature b cells does not depend on particular sites of
Ca2+ entry.
Since immature b cells secrete a greater percentage of total
cellular insulin content, it was predicted that prolonged stimula-
tion would deplete the readily releasable insulin vesicle. This was
tested by pre-incubating islets with 5.6 mM glucose for 1 hr
(degranulation), which will only stimulate high insulin secretion
from the immature b cells. As expected, there was significant
reduction of DSIS in immature b cells following pre-incubation
in 5.6mMglucose (degranulation) comparedwith untreated con-
trols, but no reduction in adult islets (Figure 1G).
Increasing cAMP levels stimulate GSIS in a Ca2+-independent
fashion (Amm€al€a et al., 1993). Yet, elevating the intracellular
cAMP level with 3-isobutyl-1-methylxanthine, an inhibitor of
the phosphodiesterase that degrades cAMP, potentiated DSIS
by 5-fold in adult islets and only 2-fold in P1 (Figure S1F).
This finding suggests that the cAMP-mediated pathway is less
active in immature b cells and unlikely to account for their hyper-
sensitive Ca2+-secretion coupling.
Collectively, our results imply that the greater DSIS of imma-
ture b cells is not a result of elevated depolarization-induced
Ca2+ influx or cAMP generation. Hence, we found that the insulin
vesicles in immature b cells undergo greater Ca2+-inducedfusion with the plasma membrane than adult islet cells, condi-
tions producing less cAMP. In the following experiments, we
will show that Syt4 regulates vesicle sensitivity to Ca2+ and
GSIS during b cell maturation.
Increased Syt4 Expression Correlates with b Cell
Maturation
RNA sequencing (RNA-seq) was performed on b cells purified
from P1, P12, and P60MipeGFPmouse islets to identify gene net-
works that change over the b cell maturation process. P1 repre-
sented immature b cells, P12 represented b cells that have
proper GSIS with no exposure to the post-weaning high
carbohydrate diet (Blum et al., 2012), and P60 represented adult
functional b cells (Stolovich-Rain et al., 2015). As expected, most
of the genes known to promote b cell maturation, includingMafA,
NeuroD1, and Ucn3 (Table S1), displayed significantly increased
expression from immature to mature state.
We focused here on vesicular genes that could regulate Ca2+-
secretion coupling. Eight of the 17 Synaptotagmin genes (Syt)
were expressed in these b cell populations (i.e., Syt3, 4, 5, 7, 9,
11, 13, and 14; Table S1). The expression change in each of
these key SNARE gene products was verified by real-time RT-
PCR in FACS-purified P1, P12, and adult b cells from a second
mouse line, RipmCherry mice. No significant difference was foundDevelopmental Cell 45, 347–361, May 7, 2018 349
in Syt5, Syt7, Syt9, and Syt13 levels, whereas themRNA levels of
Syt3, Syt4, Syt11, and Syt14 increased during islet maturation
(Figure S2A, repeated measure ANOVA, p % 0.019). Notably,
only Syt4 and Syt14 displayed significant expression changes
(>5-fold) between the P1 and P12 islets (t test; p% 0.04). Sub-
sequent analysis focused on Syt4 because its transcript levels
were 8-fold higher than Syt14 (Figure S2A). Most importantly,
this resulted in increased Syt4 production during the process
of b cell maturation (Figure 2A).
Syt4 Localizes to Both Vesicles and Non-vesicular bCell
Compartments
Super-resolution structured illumination microscopy (SIM) was
used to determine the subcellular localization of Syt4 in b cells.
SIM clearly resolved the structure of individual vesicles (Fig-
ure 2B1). Importantly, we observed that a majority of insulin
vesicles co-localized with Syt4 signals (Figure 2B2), which also
displayed granular non-uniform distribution (Figure 2B3). The
co-localization of Syt4-insulin signals was seen under 3D projec-
tion (Figure 2B) as well as single optical slice images (Figure 2C).
A small portion of bright insulin vesicles (10% in 50 b cells
examined with strong insulin immunofluorescence signals) did
not co-localize with Syt4 (Figure 2B2, arrowheads). Why these
vesicles are different from the rest of the pool is not clear, but
they may have no or only low levels of Syt4, or they may be ves-
icles in the process of being degraded by autophagy. Interest-
ingly, some strong Syt4 signals did not co-localize with insulin
vesicles (Figures 2A–2C and S2B), but in the Golgi (Figures
S2C and S2D) and the endoplasmic reticulum (ER) (Figures
S2E and S2F). Although the role of Syt4 in ER and Golgi biology
will be addressed elsewhere, we focused on the potential role of
Syt4 in regulating Ca2+-induced insulin secretion.
Syt4 Is Required for b Cell Maturation
Syt4 knockout (Syt4/) mice were used to determine the func-
tional involvement of this protein in islet b cells. Eight-week-old
Syt4/ mice displayed a modest, but significant, defect in
glucose clearance (Figure 2D), despite their normal insulin sensi-
tivity (Figure 2E). In addition, Syt4/ serum insulin levels were
lower during glucose tolerance tests (Figure 2F). GSIS in
8-week-old Syt4/ islets was also blunted compared with
controls (Figure 2G). At P10 and adult stages, Syt4/ islet and
vesicular morphology was unchanged, as were the levels of
many key endocrine genes associated with cell activity,
including the endocrine hormones, the Glut2 glucose trans-
porter, and key islet TFs (MafA, MafB, Pdx1, and Nkx6.1) (Fig-
ure S3 and data not shown). These observations indicated that
the Syt4 effect on insulin secretion in vivo was not mediated by
changes in islet cell identity or vesicular biosynthesis, but the
response of vesicles to glucose stimulation.
Interestingly, a significantly higher basal GSISwas observed in
pre-weaned, 2-week-old Syt4/ islets (Figure 2H), implying that
Syt4 increases the threshold of Ca2+ needed to trigger insulin
secretion. However, the response of these islets to high glucose
levels remained largely normal at this stage (Figure 2H), indi-
cating an overall leftward shift of Ca2+ sensitivity. This possibility
was examined using DSIS by pre-incubating mutant and control
islets in Krebs-Ringer bicarbonate buffer without glucose for 1 hr
in order to prevent glucose-induced degranulation. DSIS from350 Developmental Cell 45, 347–361, May 7, 2018non-degranulated Syt4/ islets was significantly higher than
control islets (Figure 2H), supporting the hypothesis that Syt4 re-
duces Ca2+-sensitive insulin vesicle fusion with the plasma
membrane. Notably, preventing degranulation before the DSIS
normalized insulin secretion at basal conditions (physiological
KCl) in control and Syt4/ islets, because of the increased basal
secretion in control cells (Figure 2H, showing the basal insulin
secretion levels in control islets with GSIS versus DSIS). These
changes in DSIS in Syt4/ islets were not due to Ca2+ handling,
since P14 control and Syt4/ islets had similar Ca2+ influx prop-
erties during both glucose stimulation and KCl-induced depolar-
ization (Figures 2I and 2J).
Syt4 Overexpression Represses Basal Insulin Secretion
and Impairs Islet Morphogenesis
We next examined whether precocious Syt4 overexpression
(Syt4OE) would expedite b cell maturation. Three TetO-inducible
transgenicmouse lines (termed nos 1, 2, and 3) were derived that
enabled inducible Syt4 production in TetOSyt4; RiprTTA (Syt4OE) b
cells. Syt4OE embryos/mice were exposed to doxycycline (Dox)
from embryonic day 16.5 (E16.5) via drinking water from the
plugged mice (Figure 3A). This procedure induced detectable
Syt4OE only after E17.5, which reached 6-fold in P2 islets in
all three lines (Figure 3B). Line numbers 1 and 2 were used to
test the physiological effects of Syt4OE in b cells, which resulted
in significantly repressed basal insulin secretion in perinatal islets
at P4 and P7, but without significant effect on GSIS (Figure 3C).
Corresponding to the reduced basal insulin secretion, 2-week-
old Syt4OE mice displayed a trend of higher random blood
glucose levels (i.e., 20%; Figure 3D).
We examined the islet morphologies and gene expression
patterns in P4 pancreatic sections of Syt4OE pancreas to deter-
mine if the observed differences in insulin secretion resulted from
abnormal b cell development. No differences were observed in
the expression levels/patterns of endocrine hormones (indicative
of islet morphogenesis) and key b cell markers including MafA,
MafB, Pdx1, and Glut2 (Figures S4A and S4B). These findings,
together with the P4 insulin secretion profiles, suggest that
Syt4OE reduced basal insulin secretion without compromising
b cell development or islet morphogenesis.
Interestingly, at P10, Syt4OE islets showed noticeable abnor-
malities in islet morphology, gene expression, and b cell prolifer-
ation. At this stage, >83% of islets had the typical b cell-enriched
core organization (Figure 3E1). Only 51.4% ± 3.4% of Syt4OE is-
lets had this architecture, with nearly half displaying non-b cells
in the core of islets (Figure 3E2). Moreover, Syt4OE b cells had
reduced Glut2 and increased MafB levels in b cells (Figures 3F
and 3G). In contrast, expression of several other TFs was unaf-
fected, including MafA, Myt1, Nkx6.1, and Pdx1 (Figures S4C
and S4D). Furthermore, islet b cell proliferation was significantly
compromised at P10 as assayed with Ki67 positivity (Figures 3H
and 3I), which resulted in reduced b cell mass (Figure 3J).
The abnormal islet phenotype of Syt4OE mice persisted for
nearly 4 weeks after cessation of Syt4OE upon Dox withdrawal
(P35), with non-b cells consistently observed in the center of
islets (Figure 3K) and reduced Glut2 levels on the b cell mem-
brane (Figure 3L). In contrast, MafB expression was reduced
to undetectable levels in b cells (Figure 3M). GSIS was also
compromised in Syt4OE islets (Figure 3N), and there was a trend
Figure 2. Increased Syt4 Expression Is Required for b Cell Maturation
(A) Laser scanning microscopy (LSM) confocal images of Ins/Syt4 immunofluorescence in P1 to adult b cells. Single optical slices of merged images are shown,
taken under identical confocal parameters. Note that isolated islets were partially dissociated and quickly attached onto slides with cytospin methods, followed
by fixation and staining. Under this condition, the islet vesicles appeared disrupted so that insulin immunofluorescence appeared as diffusive signals. Scale
bar, 1 mm.
(B) SIM images of Ins/Syt4 staining in a representative adult b cell. Shown are projections of 8 optical slices taken 125 nm apart, with insulin (B1), merged (B2), and
Syt4 channel (B3) shown. Arrows and arrowheads in B2 show examples of vesicles with or without co-localizing Syt4 signals. Green arrows and broken circles in
B3 highlight Syt4 patches devoid of Ins signals. Scale bar, 1 mm.
(C) An enlarged single optical slice (100 nm thickness) to highlight the co-localization of Ins and Syt4 in several vesicles (arrows). Arrowheads point to several
vesicles that are close but not contacting the Syt4 signals. Scale bar, 1 mm.
(D) IPGTT in 8-week-old control (wild-type) and Syt4 null mice. The p value is calculated with repeated measures ANOVA. Glc, glucose.
(E) Insulin sensitivity assay in 8-week-old mice after 4 hr fasting. Presented are the ratios of blood glucose levels over that before insulin injection.
(F) Serum insulin levels detected during IPGTT test (8-week-old mice).
(G) GSIS of 8-week-old Syt4/ islets.
(H) GSIS and DSIS of P14 islets.
(I and J) P14 islet cytoplasmic Ca2+ induced by 20 mM glucose (I) or 25 mM KCl (J).
Error bars represent the SEM. *p < 0.05, t test.toward defective glucose clearance in post-weaning mice (Fig-
ure 3O, p = 0.06 with repeated measure ANOVA. p < 0.05 for
time points 30 and 60 min, t test). These data suggest that tran-sient Syt4 overexpression at neonatal stages, through repres-
sing basal secretion, has long-lasting detrimental effects on islet
morphogenesis and function.Developmental Cell 45, 347–361, May 7, 2018 351
Figure 3. Syt4OE Promotes b Cell Maturation but Impairs Islet Morphogenesis and GSIS
Control ([con], including TetOSyt4 and RiprTTA mice) and Syt4OE littermates were used for all assays. Images were captured with identical parameters.
(A) The time frame used for Dox administration and islet/mouse characterization. After intercrossing, Dox feeding started at E16.5 in plugged females and last to
P10, or to the point of tissue collection before P10.
(legend continued on next page)
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Syt4 Partially Co-localizes and Interacts with Syt7 in
Islet b Cells
We next explored if interactions between Syt4 and other family
members could influence insulin secretion, a mechanism used
to regulate Ca2+-induced secretion in neurons. For example,
Syt4 binding to Syt1 reduces the efficiency of vesicle plasma
membrane fusion induced by Ca2+ (Bhalla et al., 2008; Littleton
et al., 1999). Notably, the Syt1 functional paralog, Syt7, is highly
expressed in b cells and has been found to act as a Ca2+ sensor
to promote insulin secretion (Dolai et al., 2016; Gustavsson et al.,
2008; Wu et al., 2015).
Syt7 was detected in the majority of insulin vesicles and non-
vesicular compartments when assayed using SIM, in both maxi-
projection (Figure 4A) and single optical slice images (Figure 4B).
Furthermore, Syt7 partially co-localized with Syt4 in dispersed
islet b cells (Figure 4C). Proximity ligation analysis showed that
Syt4 and Syt7 localized very close to each other (<40 nm, Figures
4D and 4E), suggesting their direct interaction. Indeed, inter-
action between these proteins was also observed in co-immuno-
precipitation assays performed in 293 cells with Syt mutant
fragments lacking their transmembrane domains to minimize
non-specific binding (Figure 4F). Moreover, insulin secretion
was severely attenuated in immature Syt7/ islets (Figure 4G).
These data are consistent with Syt4:Syt7 interactions reducing
Ca2+-induced insulin secretion in maturing b cells.
Syt4 Regulates Insulin Vesicle Localization to the
Plasma Membrane
Syt7 has been found to promote insulin vesicle transport to the
cell membrane (Dolai et al., 2016; Osterberg et al., 2015). Conse-
quently, transmission electron microscopy (TEM) was used to
determine if Syt4, presumably through interaction with Syt7,
could also affect insulin vesicle density on/near the plasma
membrane.
Although Syt4OE did not significantly change the size of
mature insulin vesicles (recognized by their dense core sur-
rounded by a ring of electron light materials, arrows in Figures
5A, 5B, and S5), it caused a 20% increase in the number of
mature vesicles in b cells at P4 and P7 (Figure 5E). In addition,
Syt4OE reduced the number of insulin vesicles docked within
20 nm of the plasma membrane (Figure 5F). In contrast, neither
insulin vesicle size nor density was changed in Syt4/ b cells
(Figure S5B), but docked vesicles density was increased in
P14 b cells when the endogenous Syt4 levels were high (Figures
5C–5F). Interestingly, Syt4/ b cells have a reduction in the
number of docked vesicles just after weaning at P24, which is
consistent with the reduced GSIS in post-weaning Syt4/ islets
(Figure 2G). These combined findings suggest that Syt4 regu-
lates the localization of insulin vesicles to the cell membrane.(B) Real-time RT-PCR showing Syt4 overexpression in isolated P2 islets of three
(C) GSIS in P4 and P7 Syt4OE islets. Shown are the percentages of insulin secre
(D) Random feeding blood glucose in control (con) and Syt4OE (OE) mice.
(E–G) Immunoassays in P10 islets with/without Syt4OE, highlighting islet morpho
(H and I) b cell proliferation assays and quantification with Ki67 labeling in P10 is
(J) b Cell mass in P10 pancreata.
(K–M) Gene expression in P35 islets in mice with/without transient Syt4OE betwe
highlight the change in Glut2 levels.
(N and O) Islet GSIS and IPGTT assays in P35 control and Syt4OE mice.
Error bars represent the SEM. Scale bars, 20 mm. *p < 0.05, t tests.Myelin TFs (Myt) Regulate Syt4 Expression
We searched for the TFs that regulate the expression of Syt4.
Inactivation of MafA did not change the expression of Syt4
(Artner et al., 2010). Strikingly, we found that total loss of Myt1,
Myt1L, and St18 production in pancreatic progenitors yielded a
phenotype similar to Syt4OE islets. Our previous work demon-
strated that expression of the Myt1 paralogs, Myt1L and St18,
were induced in the embryonic Myt1/ pancreas, a mutant
mouse with deficiencies in GSIS in adult islets (Wang et al.,
2007). Furthermore, we found that all three factors were pro-
duced in post-natal islet cells (Figure 6A). To address the overall
significance of theMyt family in the pancreas, all threeMyt genes
were inactivated in pancreatic progenitors using Pdx1Cre and
newly derived Myt1LF and St18F floxed alleles (Figure S6). This
allowed for efficient inactivation of all three genes in the endo-
crine islets of Myt1F/F; Myt1LF/F; St18F/F; Pdx1Cre mice (termed
6F; Cre, Figure 6B).
The body weight and blood glucose levels of neonatal 6F; Cre
mice were normal until about 1 week after birth compared with
wild-type, Myt1F/F; Myt1LF/F; St18F/F (6F), and Pdx1Cre control
mice. Yet the 6F; Cre mice developed elevated fasting blood
glucose several days after weaning (Figure 6C), concomitant
with reduced GSIS and DSIS, like Syt4OE islets (compare Fig-
ure 6D with Figure 3N). The 6F; Cre islets lacked visible defects
in their insulin levels, assayed by insulin immunofluorescence
(Figure 6E), and vesicular morphology, determined with TEM
(Figure 6F). These results suggest the involvement of Myt factors
with b cell function, likely involved the maturation steps.
RNA-seq was performed to analyze Syt4 levels in purified b
cells by virtue of MipeGFP expression from newly born (P1) 6F;
Cre; MipeGFP and control MipeGFP islets. There was a significant
2.4-fold upregulation of Syt4 in 6F; Cre b cells (Figure 6G).
Interestingly, we also observed significant upregulation of
NeuroD1 (1.6-fold, p = 0.002) and trends of upregulation of
Ucn3 (p = 0.14) and MafA (p = 0.16). The expression of Nkx6.1
and Pdx1 was unchanged, and Glut2 expression was signifi-
cantly decreased in the 6F; Cre b cells (Figure 6G). Increased
Syt4 expression was also observed in P14 islets (Figure 6H),
although the expression of the other genes except Glut2 was
normalized (data not shown).
The above findings suggest that the loss of Myt factors have
de-repressed Syt4 transcription, and that a normal function of
Myt proteins is to repress Syt4. This conclusion predicts that
Myt expression levels could decrease during b cell maturation
to allow for Syt4 upregulation. Indeed, theMyt1 expression level
showed a significant reduction from P1 immature to P12/adult
mature b cells, at both mRNA (Figure 6I) and protein levels (Fig-
ures 6J–6M), whereas the expression levels of Myt1L and St18
stayed relatively unchanged (Figure 6I).independent mouse lines.
tion within a 45-min time window.
logy (E), Glut2 (F), and MafB production (G).
lets.
en E16.5 and P10. Panels L1 and L2 were split, with a single Glut2 channel to
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Figure 4. Syt4 Co-localizes with Syt7 in b Cells
(A and B) SIM images showing the subcellular localization of Syt7 in a representative adult b cell. Panels in (A) are projections of 8 optical slices taken 125 nm
apart. Panels in (B) are single SIM slices for better resolution of Ins/Syt7 localization. Note the large portions of vesicles with overlapping/close localization of Ins/
Syt7 (arrows in A1 and B1). Also note the vesicles without obvious contact with Syt7 (arrowheads).
(C) Co-localization of Syt4 and Syt7 in b cells shownwith SIM. Arrows, spots of Syt4-Syt7 co-localization. Arrowheads, spots of single Syt4 or Syt7 signal. The cell
identity is confirmed by insulin expression, not included here. Scale bars, 0.5 mm.
(D and E) Proximity ligation analysis (PLA) assays verifying the close localization of Syt4 and Syt7, accepted as indication of direct association. Hand-picked islets
attached onto slideswith the cytospinmethod were used. Imageswere captured with LSM, and z stack images are presented to show signals in the entire cell (D).
Note that merged images (D1 and D3) between DAPI and PLA signal and single PLA signal images (D2 and D4) are shown. Syt4/ islet cells (D3 and D4) are
included as negative controls. Arrows and arrowheads in D2 and D4 are the positions of line-scan to compare the relative PLA signal intensity presented in (E), in
horizontal and vertical directions. Scale bar, 20 mm.
(F) Immunoprecipitation showing Syt4-Syt7 interactions. Lysates from HEK293 cells transfected with constructs that expressing hemagglutinin (HA)-tagged Syt4
and Syt7 cytoplasmic domains were used. Proteins were immunoprecipitated by anti-HA, then immuno-blotted with anti-Syt7 antibodies.
(G) GSIS of P4 Syt7/ and control immature islets. *p = 0.02, t tests.
Error bars represent the SEM.
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Figure 5. Syt4 Regulates Insulin Vesicle Docking to the Plasma Membrane
(A–D) Representative TEM images of b cells with Syt4 overexpression or inactivation. (A and B) P1 control and Syt4OE b cells. (C and D) P24 control and Syt4/
b cells. Green arrows point to several examples of docked mature vesicles. Blue arrowheads point to several immature vesicles, recognized by the low electron
density of the insulin core. The cell-cell junctions were outlined with thin broken red lines.
(E) Density of vesicles at different stage in islets of control, Syt4OE, or Syt4/ null mouse b cells.
(F) Quantification of docked vesicles in b cells. See Figure S5 for more images used for quantification.
Error bars represent the SEM. *p < 0.05.SYT4 Regulates Insulin Secretion in a Human bCell Line
SYT4 is expressed in human b cells, and as in the mouse it is
produced at higher levels in adult compared with fetal cells
(i.e., 3-fold [Blodgett et al., 2015]). With the objective of inves-
tigating whether SYT4 regulates Ca2+-secretion coupling in
human b cells, we tested the effect of SYT4 overexpression
and knockdown in human EndoC-bH1 cells. Although lentiviral
vector-mediated overexpression of SYT4 (7-fold) had little
impact on many genes’ linked b cell function (e.g., GCK,
GLUT1, INSULIN, MAFA, MAFB, NEUROD1, NKX6.1, PDX1,
and SLC30A8 [Figure 7A]), there was a significant reduction in
basal insulin secretion (p = 0.04) (Figure 7B). Moreover, reducing
SYT4 levels by 80% also had no detectable effect on the
expression of most these key b cell genes, except a 20%
reduction in INS transcripts, in EndoC-bH1 cells (Figure 7C).
Yet this knockdown significantly reduced GSIS (20 mM,
p = 0.002; Figure 7D). Interestingly, this reduction in Syt4 did
not increase basal insulin secretion (Figure 7D), as inSyt4mutant
mouse islets. However, when we examined the ratio of insulin
secretion at 20 mM over 2.8 mM glucose, we observed a strong
trend of reduced high glucose response (p = 0.08) in SYT4
knockdown cells (Figure 7E). The implication is that, at lowered
levels of SYT4, the secretable insulin vesicles had a high proba-
bility of being released at low glucose to deplete the releasable
insulin vesicles, a similar conclusion as drawn in the mouse
b cells. We also overexpressed SYT4 in human embryonicstem cell-derived b cells. Lentivirus-based transduction can
overexpress SYT4 in 30% of pancreatic progenitor cells
derived from human ESCs (Figure S7A). Although not statistically
significant, we observed a clear trend of SYT4 toward reduced
basal insulin secretion (Figure S7B). These results suggest that
the manner by which SYT4 controls insulin secretion is
conserved between rodent and humans.
DISCUSSION
Calcium is the primary signal that drives b cell GSIS. Both the
influx of Ca2+ and secretion-inducing capabilities of Ca2+ are
optimized during b cell maturation to allow for this physiological
response. However, the mechanism(s) involved in adapting to
the changes in Ca2+ influx and Ca2+ signaling during b cell matu-
ration have not been well-defined. A clearer understanding of
how Ca2+ signaling changes during maturation has the potential
to uncover post-natal b cell mechanisms that control GSIS and
thus glucose homeostasis (Jacobson and Tzanakakis, 2017).
Our results strongly suggest that Syt4 is involved in controlling
the Ca2+ sensitivity of insulin vesicle secretion during b cell matu-
ration, and Syt4 control is conserved between rodent and human
b cells.
We showed that immature b cells have high insulin secretion
despite similar levels of Ca2+ influx with mature b cells. This
observation suggests that the insulin granule fusion machineryDevelopmental Cell 45, 347–361, May 7, 2018 355
(legend on next page)
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in immature b cells is more sensitive to Ca2+. This sensitivity
was reduced during b cell maturation. Increased production
of Syt4 contributes to the regulation of this sensitivity (Fig-
ure 7F). Consistent with this model, Syt4 in neurons inhibits
the ability of Syt1 to induce Ca2+-dependent membrane
fusion. The mechanism involves Syt4 competing with Syt1 for
Syt-SNARE interactions, resulting in non-Ca2+ responsive
Syt4-SNARE complexes due to the inability of Syt4 to bind
Ca2+ (Bhalla et al., 2008). The primary Ca2+ sensor in b cells
is Syt7 (Dolai et al., 2016; Gustavsson et al., 2008; Wu et al.,
2015). Interestingly, we found that Syt4 and Syt7 are both local-
ized to the insulin vesicle and non-vesicular compartments and
they physically interact. Thus, one possibility is that Syt4 inter-
acts with and modulates the ability of Syt7 to bind with SNARE
components at the plasma membrane, with the levels of Syt4
inversely regulating insulin secretion (Figure 7F, top). Alterna-
tively, Syt4 molecules localized in the ER or Golgi could interact
with Syt7, which reduces vesicular levels of Syt7 and their
probability of release (Figure 7F, bottom). Future sensitive as-
says on Syt7 levels on mature vesicles could help to resolve
these possibilities.
Syt4 control of insulin secretion is further tuned by the size of
the RRP of insulin vesicles in b cells. Mature b cells have a limited
number of these primed insulin vesicles (Rorsman and Re-
nstro¨m, 2003). Our data extend this concept to immature b cells,
suggesting that a limited number of releasable vesicles and
higher basal insulin secretion depletes these vesicles and results
in poor GSIS. Consequently, when Syt4 is low and insulin gran-
ules are being secreted at low Ca2+ concentration, the readily
releasable insulin granules pool is predicted to become
depleted, accounting for the poor GSIS in immature b cells.
This concept is supported by the accumulation of the RRP of
vesicles following treatment of newly matured islets with
glucose-free media, which promotes DSIS. Moreover, loss of
Syt4 results in an increase in the readily releasable insulin gran-
ules, suggesting that Syt4 control of insulin granule Ca2+ sensi-
tivity modifies the quantity of insulin vesicles in RRP.
Interestingly, the insulin RRP decreases in Syt4 deficient post-
weaning mice, when islet GSIS demand increases with high car-
bohydrate diet (Stolovich-Rain et al., 2015). Along a similar line,
dysfunctional islets from type II diabetic patients expressed
lower levels of SYT4 (Andersson et al., 2012). These findings
further imply that Syt4, in conjunction with Syt7, may have spe-
cific post-natal function in regulating vesicle biosynthesis/trans-
port/docking during b cell maturation. Indeed, neuronal loss ofFigure 6. Myt Factors Repress Syt4 Transcription
(A and B)Myt protein detection in P35 control ([con], 6F in this case) and 6F; Cremu
of panels A3 and B3 to locate the islets, respectively. Scale bar, 20 mm.
(C) Fasting glucose in 6F; Cre mutant mice (*p% 0.017).
(D) Islet GSIS and DSIS of weaned mice (P24) (*p% 0.004).
(E) Immunofluorescence to show the relative insulin level in P21 control and 6F;
(F) TEM images of insulin secretory vesicles in P21 control and 6F; Cre b cells. Ar
vesicles.
(G) RNA-seq data of several genes in P1 control and 6F; Cre b cells (n = 3). The
(H) Real-time RT-PCR assays of Syt4 in hand-picked P14 islets in control and 6F
(I) Expression levels of Myt genes from purified b cells (via MipeGFP expression) a
(J–M) Immunofluorescence assays of Myt1 protein levels in b cells of different ag
used from each stage (*p% 0.04). Scale bar, 20 mm.
Error bars represent the SEM.Syt4 reduces synaptic vesicle transport to the plasma mem-
brane (Arthur et al., 2010). It will be important to determine the
unique post-natal function(s) of Syt4 in trafficking and the release
of the insulin granule pool with temporally controlled b cell-spe-
cific Syt4 loss-of-function models.
It is noteworthy that, besides Syt4, several other non-Ca2+
binding Syts (e.g., Syt11, 13, and 14) have trends or statistically
significant upregulation during mouse b cell maturation (Fig-
ure S2). Interestingly, these other Syts are also upregulated dur-
ing human b cell maturation (Blodgett et al., 2015). Thus, it is
likely that these other Syts products can work together with
Syt4 to regulate the Ca2+ sensitivity of insulin vesicles in a redun-
dant fashion. Future studies to inactivate each and/or all of these
Sytswould be interesting to test their specificity and redundancy
in modulating Ca2+-secretion coupling in b cells.
Although increasing Syt4 limited insulin secretion in neonatal
islets, high levels of Syt4 also caused compromised post-natal
islet development. This may indicate that factors secreted from
immature b cells control normal islet morphogenesis, islet gene
expression, and proliferation. Indeed, factors packaged inside
insulin vesicles such as insulin, C-peptide, insulin growth factor
2, islet amyloid polypeptide, granins, and small molecules such
as GABA and ATP (Suckale and Solimena, 2010) may have auto-
crine effects on post-natal islet development. Particularly rele-
vant to this possibility is the finding that mammalian target of ra-
pamycin (mTOR) signaling can affect islet b cell maturation
and islet morphogenesis (Sinagoga et al., 2017). Interfering
b cell secretion with Syt4 overexpression could interrupt these
signaling processes, including mTORC2, which impairs the islet
morphogenesis (Sinagoga et al., 2017). Similar examples have
been proposed in other cell types, such as peptidergic nerve ter-
minals, where changes in Syt4 levels tune neuropeptide secre-
tion, which has been proposed to influence neuroendocrine tran-
sitions (Zhang et al., 2009). Another possibility is that intracellular
Syt4 serves in regulatory capacities beyond secretion. For
example, Syt4 is localized to the Golgi in many cells such as hip-
pocampal neurons, where it plays an important role in regulating
Golgi morphology in addition to synaptic vesicle formation
(Arthur et al., 2010). As a substantial amount of b cell Syt4 local-
izes to the ER, future studies are required to examine these Syt4
effects on islet development and function; for example, by regu-
lating the general Ca2+ signaling in the ER of b cells.
The regulation of Syt4 expression remains largely unknown.
Our findings suggest that Myt proteins repress Syt4 transcription
in newborn b cells, which likely prevents the detrimental effectstant islets. Note that A4 andB4 show examples of co-staining of St18 and Pdx1
Cre b cells. Scale bar, 20 mm.
rows, examples of mature insulin vesicles. Arrowheads, examples of immature
p values (t test) of several genes were marked on the top (*p% 0.041).
; Cre islets (n = 3) (*p = 0.02).
t different post-natal stages via RNA-seq (n = 3; *p = 0.004).
es. Wild-type (CD1) mice were used. For quantification in (M), 200 cells were
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Figure 7. SYT4 Regulates Human b Cell GSIS
(A) Lentiviruswas used to introduce humanSYT4 overexpression, while small interfering RNA (siRNA)were used forSYT4 knockdown (KD). (A) Gene expression in
EndoC-bH1 cells with SYT4OE (OE), normalized against empty virus-infected control (con) cells (*p = 0.001).
(legend continued on next page)
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of precociousSyt4 activation and b cell maturation. It is not clear,
however, whether Myt factors directly repress Syt4. To this end,
Myt1L was reported to bind the promoters of several Syt genes
(Syt1, 2, 3, 7, and 12) and to mediate their repression in fibro-
blasts (Mall et al., 2017). It is likely that Myts in b cells use anal-
ogous mechanisms to repress Syt4 expression. Examining the
occupancy of the Syt4 promoter by Myts in b cells would answer
this question. Also, we do not know all the factors that upregulate
Syt4 in neonatal stages. In this regard, inactivation ofMafA does
not alter Syt4 expression (Artner et al., 2010); nor does the wean-
ing process (data not shown). Inactivation of nuclear receptor es-
trogen-related receptor gamma reduces, but does not eliminate,
Syt4 expression (Yoshihara et al., 2016). Interestingly, prolactin
receptor-mediated signaling, required for perinatal b cell devel-
opment (Auffret et al., 2013), positively regulates Syt4 expression
(Cunha et al., 2006). Moreover, different cell types appeared to
use different signals to activate Syt4 expression. For example,
diabetic conditions in humans correlated with reduced Syt4
expression in islets (Andersson et al., 2012) but increased
expression in adipose tissues (Rahimi et al., 2015). Thus, the
further identification of unknown factors and mechanisms of
Syt4 expression control is needed in order to fully understand
stimulus-secretion coupling in b cells.
Although both mouse and human b cell GSIS is modulated by
SYT4, there are significant species-related differences in how
b cells respond to Syt4manipulation. Inactivating Syt4 in mouse
b cells elevates basal insulin secretion; however, SYT4 knock-
down in human cells causes a trend toward lower basal insulin
secretion, although the GSIS in these SYT4 knockdown cells
was even lower. It is possible that Syt4 functions differently in
mouse and human cells due to the different expression profiles
of different Syt paralogs in mouse and human cells. In this re-
gard, several other SYTs with no/low Ca2+ affinity (SYT11,
SYT13, SYT14, and SYT16) also displayed increased expression
in maturing human b cells (Blodgett et al., 2015). They could
cooperate with SYT4 to regulate Ca2+-secretion coupling or
other aspects of insulin vesicle biogenesis, including insulin pro-
duction, packaging, and transport. It is also possible that the
fetal nature of EndoC-bH1 cells impinges on SYT4 impact on
basal insulin secretion. This possibility is consistent with the
high expression in EndoC-bH1 cells of many markers not found
in mature b cells such as HK1, HK2, and LDHA (Dhawan et al.,
2015). Finally, the species-related differences in GSIS could
also be due to an in vivo knockout occurring before birth versus
an acute knockdown in a cell line. Resolving this issue requires
future studies to examine the roles of different Syts in fully func-
tional b cells from both species.(B) GSIS in EndoC-bH1 cells with SYT4OE (*p = 0.04).
(C) Gene expression in EndoC-bH1 cells with SYT4KD (KD), normalized against c
(D and E) Insulin secretion in EndoC-bH1 cells with SYT4KD, presented as the pe
insulin release at 20 mM over 2.8 mM glucose (E) (*p = 0.02).
(F) A model with two pathways that converge to regulate b cell maturation: one as
membrane excitability, which ensure efficient glucose metabolism, ATP productio
the vesicles. In this pathway, immature b cells have lower levels and mature b ce
unchanged duringmaturation. The increased ratio between non-Ca2+- to Ca2+-bin
Ca2+ in the mature b cells. This desensitization can be achieved by (1) using Syt4 lo
on vesicle surface, or both.
Error bars represent the SEM.In summary, our studies reveal a previously unrecognized
Syt4-mediated mechanism that regulates b cell maturation in
both rodents and humans. Manipulating the Ca2+ sensitivity of
insulin vesicles through control of Syt4 expression, together
with altering the metabolic profiles, will likely help the production
of mature human b cells for transplantation-based diabetes
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
Mouse usage conforms to protocols approved by the Vanderbilt University IACUC for Dr. Gu, in compliance with regulations of
AAALAC. All micewere housed in a level 6 facility, in a particular room that has no detectable pathogens. Mice are housed in 51-squre
inch ages, with have autoclaved hard-wood derived bedding and ad lib access to water and chew. For new born mice, one litter will
be housed in each cage. For post weaning mice (genotyped around day 14-20), a maximum of 5 mice of same sex were housed. For
husbandry, one male mouse was housed together with two females of breeding age until cross. Plugs were checked daily to identify
plugged females, which were transferred to new cages for birth.
Wild-type CD1 (ICR) mice were from Charles River Laboratories. Flipe, RiprtTA and Syt4+/- mice were from the Jackson Labora-
tories. RipmCherry mice were derived in Vanderbilt Transgenic Mouse/ES Cell Shared Resource and reported in (Zhu et al., 2015).
The TetOSyt4, Myt1LF, and St18F mice were derived in Vanderbilt as well.
Cell Line
HEK293T. These cells were isolated from a female human embryonic kidney (HEK), transformed with large T antigen.
METHOD DETAILS
Mouse Derivation and Phenotyping
TetOSyt4mice were derived by pronuclear injection with a DNA construct made by ligating a TetO-CMV promoter (PTRE2, Clontech),
the Syt4 coding sequence, and a SV40 polyA signal. The DNA construct was verified by sequencing. Three independent lines were
derived, all without recognizable defects. For Syt4 over expression, doxycycline (2 mg/ml) was added to the drinking water of preg-
nant mice from E16.5 until P10 or to the time of tissue collection (if tissue collection was before P10). Bothmale and female mice were
included for all studies, with similar numbers of both sexes.
Myt1LF and St18F derivation used routine targeting (Figure S6). Briefly, BAC clones RP22-191C21 and RP22-214C11 were used to
isolateMyt1L and St18 genomic fragments via BAC recombineering (Warming et al., 2005). Targeting vectors were made so that the
exons 12+13 in Myt1L (coding amino acid residues 491-566) and exons 9+10 in St18 (coding amino acid resides 355-429) were
flanked with LoxP sites (Figure S6). Such designs introduced frame shifts in Myt1L and St18 mRNAs after Cre-mediated recombi-
nation. The homologous recombination arms were 7.2/2.6 kb for Myt1L and 3.1/8.2 kb for St18. Properly targeted TL1 (male) ES
cell clones were verified by southern blots on both 5’ and 3’ probes. After chimera production and selection cassette removal
with Flipe mice, PCR were used for genotyping (with DNA oligos listed in Table S2).
The functionality of the Myt1LF and St18F alleles were authenticated by producing Myt1LF/F, St18F/F, Myt1LF/F; Pdx1Cre, and
St18F/F; Pdx1Cre mice. None of these mice have detectable phenotypes. For unknown reasons that might be related with
nonsense-mediated degradation or protein instability, theMyt1LF/F; Pdx1Cre, andSt18F/F;Pdx1Cre islets did not produce detectable
N-terminal Myt1L or St18 protein fragments, which were expected to be translated from mRNAs transcribed from the Myt1L- and
St18- alleles after Cre-mediated recombination. The newly derived Myt1L and St18 antibodies used in this study were raised using
antigens localized to the N-terminal side of the deleted protein region (see information about Myt1L and St18 antibody derivation and
Figure 6B).
Glucose and Insulin Tolerance Test
For IPGTT, and ITT, mice were fasted overnight or 4 hours, respectively. Glucose or insulin was injected at 2mg/kg or 1 unit/kg via
intraperitoneal injection, respectively. Blood glucose was then measured via tail snip at the time points indicated in the manuscript.
For serum insulin assays, whole blood was collected via retro-orbital bleeding into EDTA-coated tubes. Plasma were then prepared
by centrifugation and used for down stream assays.
Pancreatic Islet Isolation
Pancreata were directly digested (for P1 and P12 pancreata) (Huang and Gu, 2017) or perfused (for pancreata older than 2 weeks)
(Zhao et al., 2010) with 0.5mg/ml Type IV collagenase dissolved in Hanks Balanced Salt Solution (HBSS) with Ca2+/Mg2+. After diges-
tion at 37C, lysates were washed in RPMI 1640 with 5.6 mM glucose and 10% fetal bovine serum (i.e. RPMIFBS) for 4 times. Islets
were handpicked for down stream usage.
Cell Purification, RNA-Seq-, and Real-Time PCR-Based Gene Expression Assays
HandpickedMipeGFP or Ripmcherry islets were washed in HBSSwithout Ca2+/Mg2+ for 5 minutes and dissociated into single cells with
0.25% trypsin at 37C as in (Gu et al., 2004). The dissociation usually lasted for less than 10 minutes. Cells were pipetted once everye3 Developmental Cell 45, 347–361.e1–e5, May 7, 2018
2 minutes to aide dissociation. When half of the cells appeared as singles, the digestion was stopped by washing with RPMIFBS
3 times in 1.5 ml tubes. Cells were then filtered, stained with propidium iodide, and sorted using a BD FACSAria III cell sorter. Live/
single/fluorescence+ cells were collected and verified under microscopes. MipeGFP mice express human growth hormone (hGH),
which can impact the expression of some genes (Brouwers et al., 2014), while Ripmcherry mice have no hGH sequence.
For RNA-seq, RNA was prepared with TRIzol (Life Technologies) and a DNA free RNATM kit following manufacturer’s protocols
(Zymo Research). 200 ng total RNAs with RINs above 8 (assessed using Agilent Bioanalyzer 2100) were sequenced, with 3 biological
replicas for each stage/genotype, following Illumina protocols on HiSeq-2000. Raw reads were processed and analyzed with TopHat
and Cufflinks to determine the relative abundance of gene expression at each stages, reported as FPKM (Fragments Per Kilobase of
transcript per Million mapped reads) (Trapnell et al., 2012). Real time RT-PCR utilized SYBR greenmaster mix of the Bio-Rad system,
with oligos listed in Table S2.
Ca2+ Clamp and GSIS/DSIS Assays in Islets
Secretion was assayed with the % of total insulin secreted within a 45-minute time window, unless noted. Hand-picked islets were
allowed to recover in RPMIFBS for2 hours or overnight. Islets were washed twice with pre-warmed KRB solution (2.8 mM glucose,
102mMNaCl, 5mMKCl, 1.2mMMgCl2, 2.7mMCaCl2, 20mMHEPES, 5mMNaHCO3, and 10mg/ml BSA, pH 7.4). Islets were then
incubated in KRB (37C) for one hour, washed with pre-warmed KRB once again. 10 islet were then transferred into each wells of
12-well plates with 1ml pre-warmed KRB to start the secretion assays. For ionomycin-mediatedCa2+ clamp, hand-picked islets were
pre-incubated with 0.25 mM diazoxide for one hour. 50 mM ionomycin was then added to induce insulin secretion. For all assays, at
least six mice of each genotype were used for islet isolation, with islets from two or more mice examined in each independent exper-
iment (as three-four technical replicas).
Insulin was assayed with Elisa kit from Alpco following manufacturer protocol. For assaying insulin per cell, specific numbers of
sorted cells were directly extracted with ethanol-HCl for total insulin quantification (Zhao et al., 2010).
Immunolabeling, b-Cell Mass Assays, and Electron Microscopy
Immunoflorescence staining followed published procedures (Wang et al., 2007, 2010) with antibodies in the Key Resources Table.
Briefly, tissue sections or cells attached on slides were washed in 1XPhosphate Buffered Saline (PBS) 3 time, 5 minutes each. The
frozen sections were permeabilized in basal staining buffer (1XPBS+ 0.1% triton X100 + 0.1%Tween-20) for 30minutes at room tem-
perature (slides from paraffin embedded tissues did need permeabilization). Samples were blocked with blocking buffer (1XPBS+
0.1% triton X100 + 0.1% Tween-20 + 0.1% BSA + 0.05% donkey serum, 100 micro-litter per slide) for another 30 minutes at
room temperature. Primary antibodies (100 micro-litter per slide) diluted in blocking buffer were then added (see below for dilution)
and incubate at 4C overnight. After three time wash in basal staining buffer, secondary antibodies diluted in blocking buffer were
overlaid on slides (100 micro litter each slide), incubate for 1 hour at room temperature, washed three times with basal buffer, and
mounted for observation. All primary and secondary antibodies except that against Syt4 (1:200 dilution) and Syt7 (1:500 dilution)
used 1:1000 dilutions.
For hormones and transcription factor staining, frozen or paraffin tissue sections were both used. Tissue section preparations fol-
lowed routine procedures: pancreata were dissected; large pancreata (older than P14) were cut into 5-10 small pieces and fixed in
4% paraformaldehyde overnight at 4C; fixed tissues were washed with PBS 3 times (10 minutes each) and prepared for frozen or
paraffin blocks (following dehydration through PBS, 40%, 70%, 85%, 100%ethanol, andHistoClear; 15 and 6 mm thick sectionswere
prepared for frozen and paraffin sections, respectively. For antibodies against Syt4, Syt7, GM130, and PDI, islet cells attached to
glass coverslips were used. For Syt4 quantification, post-fixation (after freshly isolated islets were partially dissociated and attached
onto slides with cytospin) was used, which appeared to produce better dynamic range of immunofluorescence signals. For subcel-
lular localization, islets were isolated and partially dissociated into small cell clusters (5-20 cells per cluster) with trypsin. Cells were
then cultured on glass coverslips coated with human fibronectin in RPMIFBS. After 24 hours, samples were fixed in 4% paraformal-
dehyde for 15 minutes and processed for immunolabeling. Paraffin sections were de-waxed through HistoClear, 100%, 85%, 70%,
40% ethanol, and PBS solutions for antibody staining.
For co-labeling with antibodies raised in the same host (amongst PDI, Syt4, and Syt7), one round of labeling would be completed
first with proper fluorophore-conjugated secondary antibodies. The samples were blocked with anti-IgG of the host, followed by
routine labeling for the second antibody with another fluorophore.
Guinea-pig anti Myt1L and rat anti-St18 were raised against the amino acids 267-493 and 60-297 of each protein, respectively.
Recombinant proteins were produced (as GST-fusion proteins) and purified and sent to Strategic Bio-Solutions (Newark, De) for anti-
body production in guinea pig and rat, respectively. Final bleeds were obtained 45 days after immunization.
For imaging, laser scanning microscopy (LSM) and structured illumination microscopy (SIM) were used. When expression levels of
a protein between samples were compared, slides/cells were processed side-by-side, and images were captured utilizing identical
optical/electronic settings. For protein level quantification in nuclei, LSM images taken under identical parameters were selected for
Image J-based particle quantification.
Transmission electron microscopy (TEM) followed established procedure (Zhao et al., 2010). Briefly, handpicked islets were fixed
in 2.5% glutaraldehyde in 0.1M cacodylate buffer (pH 7.4) overnight at room temperature. Islets were then washed and treated in 1%
osmium tetroxide in 0.1M cacodylate buffer for 1 hour. Islets were then washed, embedded, thin-sectioned for imaging.Developmental Cell 45, 347–361.e1–e5, May 7, 2018 e4
Proximity Ligation Assays (PLA), Co-Immunoprecipitation, and Western Blotting
For PLA, islets from adult control and Syt4-/-mice were isolated and dissociated into small clusters with trypsin (5-20 cells/cluster).
Cytospin were used to attach cells onto slides, followed by fixation with 4% paraformaldehyde for 15 minutes at room temperature.
PLA strictly followed manufacturer’s instruction. For immunoprecipitation, HEK293T cells were co-transfected with plasmids ex-
pressing the cytoplasmic C2 domains of Syt4 (tagged by HA) and Syt7. 48 hours after transfection, cells were lysed by co-IP Buffer
(150 mM NaCl, 8 mM Na2HPO4, 2 mM NaH2PO4, 1% NP-40, 0.5% sodium deoxycholate, protease inhibitor cocktails). Cell lysates
were mixed with anti-HA magnetic beads (at 4C for 4 h. The beads were washed with TBST (20 mM Tris-HCl pH7.6, 150 mM NaCl,
0.1% Tween-20) five times, and bound proteins were analyzed by Western blotting.
Free Cytoplasmic Ca2+ Recording
Ca2+ recording and analysis followed published methods (Jacobson et al., 2010). Briefly, islets were cultured on ploy-lysine coated
glass for 48 hours in RPMI medium containing 10%FBS and 11mMglucose. Islets were loaded with 2mMFURA2AM (Invitrogen) for
25 minutes in culture medium followed by 20 min starvation in REC buffer (119 mM NaCl, 2.5 mMCaCl2, 4.7 mM KCl, 10 mMHepes,
1.2 mM MgSO4 and 1.2 mM KH2PO4) with 2mM glucose. Islets were then transferred to REC buffer with 2.8 mM glucose for three
minutes for recording before stimulation. Buffer changes were achieved by perfusion at 2 ml/min. Stimulating glucose and KCl were
20 and 25mM, respectively. Imagingwas performed using a Nikon Eclipse TE2000-Umicroscope. The ratios of emitted fluorescence
intensities at excitation wavelengths of 340 and 380 nm (F340/F380) were determined every 5 second. The total Ca2+ was calculated
using a fura-2 calibration kit (Grynkiewicz et al., 1985).
Gene Expression and GSIS Assays in Human EndoC-bH1 Cells
Human EndoC-bH1 cells were grown in DMEM containing 5.6 mM glucose, 2% BSA, 50 mM 2-mercaptoethanol, 10 mM nicotin-
amide, 5.5 mg/mL transferrin, 6.7 ng/mL selenite, 100 units/mL penicillin, and 100 units/mL streptomycin (Ravassard et al., 2011).
For gene overexpression, cells were infected with lentiviral particles (carrying a human SYT4 full coding region and eGFP reporter)
one day after plating. For siRNA transfection (with a mix of three individual siRNAs), dissociated cells were incubated with siRNA (at
100 nana-molar concentration, with RNAiMax) for 5minutes before plating. Gene expression assays were performed three days after
infection or transfection. For GSIS, cells were incubated with 1mM glucose overnight, briefly washed three times using KRB with
2.8 mM glucose, before insulin secretion assays as described above. The cells were equilibrated in KRB with 2.8 mM glucose for
1 hour before GSIS assays.
QUANTIFICATION AND STATISTICAL ANALYSIS
All experiments contained at least two biological replicas and two technical replicas. For quantifications of b cell mass and replication
index throughout the pancreas, the frozen pancreatic block was sectioned at 20 mm intervals. One third of all sections were labeled
and scanned using Aperio Scanscope. b-cell mass was then calculated based on the total pancreas weight and the percentage of
tissues area that labeled for insulin. For vesicle quantification, images from different sections were used. 30-50 images from different
b cells were counted, under double-blind settings (image capture and vesicle counting were done by different personnel).
Statistical analyses utilized standard student T test for pairwise comparisons or One-way ANOVA for comparing multiple groups of
data points. A P-value of 0.05 or lower was considered significant. Quantification data were presented as (mean ± SEM). For all as-
says the ‘‘n’’ noted in all figures andmanuscript referred to the number of independent experiments, including both biological replicas
and technical replicas.
DATA AND SOFTWARE AVAILABILITY
The accession numbers for b-cell RNA-seq reported in this paper are E-MTAB-2266 (https://www.ebi.ac.uk/arrayexpress/
experiments/E-MTAB-2266/) and E-MTAB-6615 (https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-6615/).e5 Developmental Cell 45, 347–361.e1–e5, May 7, 2018
